Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuriye Ozdemir

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|October 16, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumorsNuriye Ozdemir, Ozan Yazici, Nurullah Zengin
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 21, 2017
Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapyYakup Bozkaya, Nuriye Ozdemir, Aysel Colak, et al.
BMJ Supportive & Palliative Care|December 23, 2020
Harmful consequences of COVID-19 fear in patients with cancerOsman Sutcuoglu, Ozan Yazici, Ahmet Ozet, et al.
World Journal of Gastroenterology|January 27, 2016
Targeted therapies in gastric cancer and future perspectivesOzan Yazici, M Ali Nahit Sendur, Nuriye Ozdemir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2026
Key Methodological Considerations in the Interpretation of the CONKO-007 TrialOrhun Akdogan, Ahmet Ozet, Ozan Yazıcı, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|October 14, 2015
The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experienceMutlu Dogan, Tulay Eren, Nuriye Ozdemir, et al.
The Lancet. Gastroenterology & Hepatology|January 12, 2024
Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trialKadriye Bir Yücel, Osman Sutcuoglu, Ozan Yazıcı, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2025
FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized StrategiesOrhun Akdogan, Osman Sutcuoglu, Tuba Ugur Tuzcu, et al.
Cureus|December 30, 2024
Comparative Analysis of Whole-Body Diffusion-Weighted Imaging and PET/CT in Metastasis Detection: A Prospective StudyBetul Akdal Dolek, Deniz Sozmen Ciliz, Nuriye Ozdemir, et al.
Journal of Cancer Policy|May 7, 2025
Evaluation of treatment protocols based on the ESMO-magnitude of clinical benefit scale for gastrointestinal system cancers and their relationship with reimbursement policies in TurkeyOrhun Akdogan, Osman Sutcuoglu, Kadriye Bir Yucel, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|October 16, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumorsNuriye Ozdemir, Ozan Yazici, Nurullah Zengin
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 21, 2017
Gastric adenocarcinoma with neuroendocrine differentiation: Clinicopathological features and efficacy of modified DCF chemotherapyYakup Bozkaya, Nuriye Ozdemir, Aysel Colak, et al.
BMJ Supportive & Palliative Care|December 23, 2020
Harmful consequences of COVID-19 fear in patients with cancerOsman Sutcuoglu, Ozan Yazici, Ahmet Ozet, et al.
World Journal of Gastroenterology|January 27, 2016
Targeted therapies in gastric cancer and future perspectivesOzan Yazici, M Ali Nahit Sendur, Nuriye Ozdemir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2026
Key Methodological Considerations in the Interpretation of the CONKO-007 TrialOrhun Akdogan, Ahmet Ozet, Ozan Yazıcı, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|October 14, 2015
The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experienceMutlu Dogan, Tulay Eren, Nuriye Ozdemir, et al.
The Lancet. Gastroenterology & Hepatology|January 12, 2024
Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trialKadriye Bir Yücel, Osman Sutcuoglu, Ozan Yazıcı, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2025
FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized StrategiesOrhun Akdogan, Osman Sutcuoglu, Tuba Ugur Tuzcu, et al.
Cureus|December 30, 2024
Comparative Analysis of Whole-Body Diffusion-Weighted Imaging and PET/CT in Metastasis Detection: A Prospective StudyBetul Akdal Dolek, Deniz Sozmen Ciliz, Nuriye Ozdemir, et al.
Journal of Cancer Policy|May 7, 2025
Evaluation of treatment protocols based on the ESMO-magnitude of clinical benefit scale for gastrointestinal system cancers and their relationship with reimbursement policies in TurkeyOrhun Akdogan, Osman Sutcuoglu, Kadriye Bir Yucel, et al.
Pageof 7